← All organizations

South China Research Center for Stem Cell and Regenerative Medicine

Academic/Hospital

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Mar 1, 2018

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 6 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

autologous bone marrow derived mesenchymal cells

Indications

Studied for

Recent trials (6)

NCT02993809Lead sponsorPhase 1Mar 1, 2018
NCT02815423Lead sponsorPhase 1/Phase 2Jan 1, 2017
NCT02698813Lead sponsorPhase 1Dec 1, 2016
NCT02776943Lead sponsorPhase 1/Phase 2Jun 1, 2016
NCT02666391Lead sponsorPhase 1/Phase 2May 1, 2016
NCT02672306Lead sponsorPhase 1/Phase 2May 1, 2016

Details

Last known activity: Mar 1, 2018

Notes

a research unit of Guangzhou Institutes of Biomedicine and Health (http://english.gibh.cas.cn/about/at/)